Education
About Us
Working with TipRanks
Follow Us
Hyperion DeFi (HYPD)
NASDAQ:HYPD
HYPD Stock Chart & Stats
$3.70
--
Market closed
$3.70
--
Day’s Range― - ―
52-Week Range$0.85 - $17.92
Previous CloseN/A
VolumeN/A
Average Volume (3M)1.09M
Market Cap
$37.68M
Enterprise Value$37.46M
Total Cash (Recent Filing)$8.22M
Total Debt (Recent Filing)$8.49M
Price to Earnings (P/E)―
Beta3.30
Next Earnings
May 07, 2026EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)0.05
Shares Outstanding6,959,159
10 Day Avg. Volume701,310
30 Day Avg. Volume1,085,571
Financial Highlights & Ratios
PEG Ratio-0.01
Price to Book (P/B)-0.50
Price to Sales (P/S)114.63
P/FCF Ratio-0.22
Enterprise Value/Market Cap0.99
Enterprise Value/Revenue108.49
Enterprise Value/Gross Profit-11.95
Enterprise Value/Ebitda-1.61
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusHold
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Collaboration OpportunitiesCollaborations in dry eye disease development are seen as upside, with the user-filled Optejet potentially defining the most realistic shot for near-term progress.
Merger And DevelopmentThe proposed merger of topical ophthalmic platforms could present the next constructive chapter for Optejet and broader development.
Technological AdvancementThe new user-filled Optejet incorporates a sterile disposable cartridge that can be user-filled from a traditional eyedropper bottle, allowing consistent and precise spray delivery.
Bears Say
Clinical Trial ChallengesThe Phase 3 CHAPERONE trial failure for MicroPine has informed the assumptions for the price target.
Discontinued TrialsThe Phase 3 CHAPERONE trial using the Optejet optimized spray dispenser for delivering MicroPine atropine for reduction of pediatric progressive myopia was discontinued.
Market And Revenue RisksRisks to the investment thesis include failure of products and/or candidates to achieve peak commercial revenue estimates due to market size, penetration rates, and/or pricing.
Hyperion DeFi News
HYPD FAQ
What was Hyperion DeFi’s price range in the past 12 months?
Hyperion DeFi lowest stock price was $0.85 and its highest was $17.92 in the past 12 months.
What is Hyperion DeFi’s market cap?
Hyperion DeFi’s market cap is $37.68M.
When is Hyperion DeFi’s upcoming earnings report date?
Hyperion DeFi’s upcoming earnings report date is May 07, 2026 which is in 155 days.
How were Hyperion DeFi’s earnings last quarter?
Hyperion DeFi released its earnings results on Nov 13, 2025. The company reported $0.05 earnings per share for the quarter, beating the consensus estimate of N/A by $0.05.
Is Hyperion DeFi overvalued?
According to Wall Street analysts Hyperion DeFi’s price is currently Overvalued.
Does Hyperion DeFi pay dividends?
Hyperion DeFi does not currently pay dividends.
What is Hyperion DeFi’s EPS estimate?
Hyperion DeFi’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hyperion DeFi have?
Hyperion DeFi has 6,959,159 shares outstanding.
What happened to Hyperion DeFi’s price movement after its last earnings report?
Hyperion DeFi reported an EPS of $0.05 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went up 0.805%.
Which hedge fund is a major shareholder of Hyperion DeFi?
Currently, no hedge funds are holding shares in HYPD
Hyperion DeFi Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Hold
Average Price Target:
― (―)
― (―)
Crowd Wisdom
Very Negative
Last 7 Days ▼ 1.3%
Last 30 Days ▼ 1.6%
Last 30 Days ▼ 1.6%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-82.11%
12-Months-Change
Fundamentals
Return on Equity
-68.49%
Trailing 12-Months
Asset Growth
193.02%
Trailing 12-Months
Company Description
Hyperion DeFi
Hyperion DeFi (HYPD) is a decentralized finance platform that aims to provide innovative financial solutions through blockchain technology. Operating primarily in the fintech sector, Hyperion DeFi offers a suite of products including yield farming, liquidity pools, and decentralized exchanges (DEXs), enabling users to earn passive income and trade cryptocurrencies with minimal fees. By leveraging smart contracts and DeFi principles, Hyperion DeFi focuses on enhancing financial accessibility and empowering users with greater control over their assets.
HYPD Company Deck
HYPD Earnings Call
Q3 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a positive transformation and growth trajectory for Hyperion DeFi, marked by record financial metrics, successful strategic initiatives, and promising guidance. However, challenges related to regulatory uncertainty and reliance on nonrecurring gains were noted.View all HYPD earnings summariesTechnical Analysis
Cytosorbents
―
Sensus Healthcare
―
TELA Bio
―
Icecure Medical
―
Baird Medical Investment Holdings
―
Ownership Overview
30.77% Insiders
3.63% Mutual Funds
1.43% Other Institutional Investors
63.33% Public Companies and
Individual Investors
Options Prices
Currently, No data available
---